NewsRoom Articles

MondayOct 19, 2026 10:00 am

New Vaccine Shows Potential to Extend Lives of Brain Cancer Patients

A new therapeutic vaccine has shown early promise in extending the lives of patients with aggressive brain tumors, with two-thirds of participants in a small German study still alive eight years on from their enrollment. Results from the long-term follow-up, published in the journal Nature, also showed that 42% of participants had seen no recurrence during that period, a figure that surprised even the researchers involved. The vaccine was developed by scientists at the German Cancer Research Center, University Medical Center Mannheim and Heidelberg University Hospital, among other institutions. Its target is a mutation in the IDH1 enzyme that generates…

WednesdayOct 14, 2026 10:00 am

Expert Shares the Latest Testing and Screening Advances in Breast Cancer Treatment

Artificial intelligence and a new generation of imaging tools are beginning to reshape breast cancer detection, moving the field toward earlier identification and more personalized screening recommendations. About one in eight women will develop breast cancer in their lifetime, but the five-year survival rate reaches 90% to 100% when caught early, making detection advances among the most consequential developments in the field. Aashini Master, medical oncologist and High-Risk Breast Clinic director at UCLA Health, said AI is already being woven into the diagnostic workflow, helping radiologists read mammograms more accurately and flag cancers that might otherwise go undetected. Risk-based screening,…

MondayOct 12, 2026 10:00 am

Renewable Energy Helps America Navigate the Summer Heat

Renewable power helped the United States get through a punishing summer, absorbing a surge in electricity demand that many expected would force utilities back toward coal and gas. Cooling needs and server farms pushed the grid harder than at almost any point in recent memory, yet fossil-fuel generation barely budged. Record wind, solar and battery output picked up the slack instead. Electricity load across Texas climbed about 4% over the first nine months of the year, a notable rise on its own, but clean generation grew nearly three times as fast, up more than 11%. Solar output surged roughly 26%,…

WednesdayOct 07, 2026 10:00 am

US, UAE Make Progress on Partnership Covering Quantum Computing, Space and AI

Washington and Abu Dhabi pushed their technology partnership forward last week through three days of high-level talks covering artificial intelligence, space, cybersecurity, quantum computing, and export policy. The discussions build on a $1.4 trillion investment framework the two countries agreed to in March 2025, with a UAE delegation led by Asst. Foreign Minister for Advanced Science & Technology Affairs Omran Sharaf meeting officials across the Commerce Department, State Department, and White House. Central to the talks was the UAE's A:5 export-control designation, a status that streamlines technology trade between the two nations and gives approved Emirati entities secure access to…

TuesdayOct 06, 2026 9:00 am

BTQ Technologies Corp. (NASDAQ: BTQ) (CBOE CA: BTQ) Is ‘One to Watch’

Disseminated on behalf of BTQ Technologies Corp. and may include paid advertisements. BTQ provides public-market exposure to a trusted quantum infrastructure platform spanning hardware-rooted post-quantum security, quantum-secure networks and quantum computing technologies. The company is advancing multiple technologies toward commercialization, with QSSN surpassing 100,000 mainnet transactions, MIMIQ in commercial distribution and QCIM progressing through semiconductor validation and productization. QCIM addresses a company-identified $1 trillion post-quantum cryptography semiconductor market opportunity by 2035 with a crypto-agile architecture designed to adapt as cryptographic standards evolve. The July 2026 acquisition of QPerfect added a wholly owned quantum computing platform with commercially deployed MIMIQ software…

MondayOct 05, 2026 10:00 am

NHS England Unveils Rapid Test for Brain Tumors

Surgeons can now identify a brain tumor's genetic makeup before a patient even leaves the operating table, cutting what used to be an eight-week wait for diagnosis down to about two hours. The Brain Tumor Research Center of Excellence at the University of Nottingham built the tool, and the NHS has already begun putting it to use. Genomic analysis sits at the core of the gamechanging technology. Small tissue samples travel from the tumor site to a pathology lab, where a sequencing device roughly the size of a shoebox, built by Oxford Nanopore, threads strands of DNA through microscopic pores.…

FridayOct 02, 2026 10:30 am

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) Joins Canadian Research Consortium in Terry Fox-Funded Oncology AI Project

Disseminated on behalf of Redwood AI Corp.and may include paid advertising. The company has been named a co-applicant in a competitive Terry Fox Research Institute grant awarded to advance Onco-Innovations’ SynoGraph(TM) oncology platform. The project will investigate whether causal AI can improve predictions of first-in-human clinical outcomes using preclinical and real-world clinico-genomic data. Redwood AI will contribute proprietary data integration and physicochemical modelling methods to expand SynoGraph’s predictive capabilities. The grant supports a project with an estimated budget of $3.5 million and reimburses eligible costs up to 25% of that amount. Academic partners will provide clinico-genomic and imaging data for research…

ThursdayOct 01, 2026 9:45 am

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) Completes Quantum.IQ Acquisition, Adding Quantum-Resistant Cybersecurity to Its AI Platform

Disseminated on behalf of Redwood AI Corp. and may include paid advertising. Redwood adds Quantum.IQ software, focused on cryptographic visibility, quantum-readiness assessment, and planning for migration toward post-quantum security. The acquired platform is designed for organizations in government, defense, financial services, and critical infrastructure where long-term data protection is particularly important. Redwood agreed to issue up to 14,033,558 common shares as consideration, with a portion subject to milestone conditions and escrow arrangements. The transaction expands Redwood beyond its core AI-powered chemistry platform, including Reactosphere, into a cybersecurity application tied to the anticipated transition to quantum-resistant encryption. Redwood AI (CSE: AIRX)…

WednesdaySep 30, 2026 10:00 am

2 Billion Pounds of Cancer-Causing Chemicals Found Their Way into America in 2020

Chemicals suspected of raising the risk of breast cancer entered America's air by the billions of pounds within one recent year, settling into a pattern that stretches across daily life. The exposure shows up in outdoor air, tap water, food, and the products sitting on household shelves, all traced back to the same body of research. That research started from 920 chemicals already shown to cause breast tumors in animal studies or disrupt hormone activity. Investigators then checked how often those substances turn up in products people actually use, cross-referencing federal records on manufacturing, pesticide registration, food ingredients, and drug…

MondaySep 28, 2026 9:45 am

Azio AI Holdings Inc. (NASDAQ: AZIO) Unveils Flagship Atlas One Project to Tackle AI’s Power Shortage

Utility power for large data centers can take years to secure, and demand continues to rise faster than the grid can expand to meet it. Atlas One is Azio AI Holdings’ answer to that pressure; the project spans more than 548 acres in south Texas and is engineered for up to 500 megawatts of planned behind-the-meter power capacity. The name Atlas One reflects a broader naming convention the company plans to use going forward, tying separate land, power and fiber updates together under one project. Building an AI data center is no longer just about buying enough graphical processing units…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000